Literature DB >> 28110925

Airway adverse events following posterior occipito-cervical spinal fusion.

Veena Sheshadri1, Rebecca Moga2, Pirjo Manninen3, Christina L Goldstein4, Yoga Raja Rampersaud5, Eric M Massicotte6, Michael G Fehlings7, Lashmi Venkatraghavan8.   

Abstract

Management of the airway may be challenging in patients undergoing occipito-cervical spine fusions (OCF). Changes in the occipito-cervical angle (dOC2A) of fusion after surgery may result in acute airway obstruction, dyspnea and/or dysphagia. Objectives of the study were to review the airway management of patients during posterior OCF, determine the incidence, nature and risk factors for postoperative airway adverse events (AEs), and to determine the relationship between airway AEs and the change in dOC2A. In this retrospective cohort of 59 patients, following extubation in the operating room (OR), there were no complications in 43 (73%) patients (Group 1). Sixteen (27%) patients (Group 2) had airway complications; 4 requiring reintubation and 12 having delayed extubation. The number of vertebral levels fused (>6), presence of difficult intubation and duration of surgery (>5h) were significantly associated with AEs. There was no significant difference in the dOC2A between the groups (-1.070±5.527 versus -4.375±10.788, p=0.127). Airway management in patients undergoing OCF poses a challenge for the anesthesiology and surgical teams. The incidence of AEs was 27%. The decision to extubate immediately after surgery needs to be individualized. Factors such as difficult intubation, number of vertebral levels fused and duration of surgery have to be considered. A significant correlation between dOC2A and postoperative AEs could not be established. Risk factors for postoperative AEs are multifactorial and prospective evaluation of these factors is indicated.
Copyright © 2016 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Airway adverse events; Airway management; Occipito-cervical angle; Occipito-cervical complex; Occipito-cervical fusion

Mesh:

Year:  2017        PMID: 28110925     DOI: 10.1016/j.jocn.2016.12.036

Source DB:  PubMed          Journal:  J Clin Neurosci        ISSN: 0967-5868            Impact factor:   1.961


  6 in total

1.  Characteristics of deformity surgery in patients with severe and rigid cervical kyphosis (CK): results of the CSRS-Europe multi-centre study project.

Authors:  H Koller; C Ames; H Mehdian; R Bartels; R Ferch; V Deriven; H Toyone; C Shaffrey; J Smith; W Hitzl; J Schröder; Yohan Robinson
Journal:  Eur Spine J       Date:  2018-11-27       Impact factor: 3.134

2.  Importance of the Occipitoaxial Angle and Posterior Occipitocervical Angle in Occipitocervical Fusion.

Authors:  Chao Tang; Guang Zhou Li; Ye Hui Liao; Qiang Tang; Fei Ma; Qing Wang; De Jun Zhong
Journal:  Orthop Surg       Date:  2019-11-19       Impact factor: 2.071

3.  Atypical Occipitocervical Dissociation Associated with Ossification of the Posterior Longitudinal Ligament and Diffuse Idiopathic Skeletal Hyperostosis in Low-Energy Trauma.

Authors:  Bassam H Alahmadi; Hadeel H Alalawi; Abdullah H Alahmadi; Abdulmuhsen N Alshammari
Journal:  J Orthop Case Rep       Date:  2020-11

4.  Perioperative Management of a Child with Klippel-Feil Syndrome and Severe Uncorrected Aortic Stenosis Undergoing Cervical Spine Stabilization.

Authors:  Bhagya Ranjan Jena; Rajeeb Kumar Mishra; Surya Kumar Dube; Girija Prasad Rath; Vishwas Malik; Hitesh Kumar Gurjar
Journal:  J Pediatr Neurosci       Date:  2022-01-07

5.  Revision surgery after rod breakage in a patient with occipitocervical fusion: A case report.

Authors:  Chao Tang; Guang Zhou Li; Min Kang; Ye Hui Liao; Qiang Tang; De Jun Zhong
Journal:  Medicine (Baltimore)       Date:  2018-04       Impact factor: 1.889

6.  A novel method for measurement of the occipital-cervical distance via the occiput-C4 distance.

Authors:  Chao Tang; Sheng Yang; Ye Hui Liao; Qiang Tang; Fei Ma; Qing Wang; De Jun Zhong
Journal:  BMC Musculoskelet Disord       Date:  2020-06-15       Impact factor: 2.362

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.